Blume Capital Management’s Zimmer Biomet ZBH Stock Holding History

Blume Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Buy	+24,150	New	+$2.12M	0.3%	66
2022 Q4	–	Sell	-10	Closed	-$1K	–	332
2022 Q3	$1K	Hold	10	–	–	﹤0.01%	306
2022 Q2	$1K	Sell	10 -100	-91%	-$11.9K	﹤0.01%	308
2022 Q1	$14K	Buy	110 +100	+1,000%	+$12.1K	﹤0.01%	242
2021 Q4	$1K	Hold	10	–	–	﹤0.01%	298
2021 Q3	$1K	Sell	10 -21	-68%	-$3.09K	﹤0.01%	299
2021 Q2	$5K	Sell	31 -135	-81%	-$21.9K	﹤0.01%	260
2021 Q1	$26K	Buy	+166	New	+$25.7K	0.01%	191
2018 Q2	–	Sell	-155	Closed	-$16K	–	226
2018 Q1	$16K	Buy	+155	New	+$18K	0.01%	163

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Blume Capital Management's ZBH Position: Q2 2026 in Review

Blume Capital Management opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 24,150 shares worth $2.08M. The stake represents 0.3% of the portfolio and ranks #66 among its holdings. This is a return to the name: Blume Capital Management previously reported a position in ZBH as recently as Q3 2022.

Blume Capital Management first reported a position in ZBH in Q1 2018 and has held it in 9 quarters since. 910 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Blume Capital Management held 24,150 shares of Zimmer Biomet worth $2.08M as of Q2 2026.
Zimmer Biomet was a new Blume Capital Management position in Q2 2026.
Zimmer Biomet made up 0.3% of Blume Capital Management's portfolio in Q2 2026, its #66 holding.
Blume Capital Management first reported a position in Zimmer Biomet in Q1 2018 and has held it in 9 quarters since.
910 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.